Trials / Completed
CompletedNCT00002306
A Study of Fluconazole in the Treatment of Cryptococcal Meningitis in Patients Who Have Not Had Success With Amphotericin B
Multi-Center Evaluation of Fluconazole (UK-49,858) as Treatment for Acute Cryptococcal Meningitis in Patients Who Have Failed to Respond or Have Experienced Unacceptable Toxicity During Treatment With Amphotericin B
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Pfizer · Industry
- Sex
- All
- Age
- 13 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the safety and effectiveness of fluconazole as treatment for acute cryptococcal meningitis in patients who have had an unsatisfactory response to or have experienced unacceptable toxicity with amphotericin B.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Fluconazole |
Timeline
- First posted
- 2001-08-31
- Last updated
- 2005-06-24
Locations
14 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00002306. Inclusion in this directory is not an endorsement.